Terms: = Uterine cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2
54 results:
1. Integrated In-Silico and In Vitro analysis to Decipher the contribution of bisphenol-A in cervical cancer.
Khan NG; Adiga D; Rai PS; Kabekkodu SP
Toxicology; 2024 May; 504():153791. PubMed ID: 38555994
[TBL] [Abstract] [Full Text] [Related]
2. Mutational landscape of head and neck cancer and cervical cancer in Chinese and Western population.
Li Q; Zhu G; Zhang L; Zeng B; Cai T; Wu J; Wei B; Xie Z; He L; Tang W; Lin X; Lu H; Wu F; Huang J; Hu H; Liu N; Fan S
Head Neck; 2024 Mar; 46(3):528-540. PubMed ID: 38111234
[TBL] [Abstract] [Full Text] [Related]
3. Molecular biological analysis revealed a case of synchronous endometrial and ovarian cancer with different histological grade as metastatic ovarian cancer from endometrial cancer: Case report and review of literature.
Yumisashi R; Saito R; Togami S; Kobayashi Y; Kitazono I; Tanimoto A; Kobayashi H
J Obstet Gynaecol Res; 2023 Nov; 49(11):2766-2770. PubMed ID: 37604499
[TBL] [Abstract] [Full Text] [Related]
4. Human papillomavirus integration perspective in small cell cervical carcinoma.
Wang X; Jia W; Wang M; Liu J; Zhou X; Liang Z; Zhang Q; Long S; Quzhen S; Li X; Tian Q; Li X; Sun H; Zhao C; Meng S; Ning R; Xi L; Wang L; Zhou S; Zhang J; Wu L; Chen Y; Liu A; Ma Y; Zhao X; Cheng X; Zhang Q; Han X; Pan H; Zhang Y; Cao L; Wang Y; Ling S; Cao L; Xing H; Xu C; Sui L; Wang S; Zhou J; Kong B; Xie X; Chen G; Li S; Ma D; Li S
Nat Commun; 2022 Oct; 13(1):5968. PubMed ID: 36216793
[TBL] [Abstract] [Full Text] [Related]
5. Genomic Correlates of Unfavorable Outcome in Locally Advanced Cervical cancer Treated with Neoadjuvant Chemoradiation.
Wei Y; Wei C; Chen L; Liu N; Ou Q; Yin JC; Pang J; Fang Z; Wu X; Wang X; Mu D; Shao Y; Yu J; Yuan S
Cancer Res Treat; 2022 Oct; 54(4):1209-1218. PubMed ID: 35038823
[TBL] [Abstract] [Full Text] [Related]
6. Cervical Precancers Originate From Infected Proliferating Reserve Cells: A Comparative Histologic and Genetic Study of Thin and Thick High-grade Squamous Intraepithelial Lesions.
Regauer S; Reich O; Kashofer K
Am J Surg Pathol; 2022 Apr; 46(4):519-527. PubMed ID: 34619706
[TBL] [Abstract] [Full Text] [Related]
7. A clear cancer cell line (150057) derived from human endometrial carcinoma harbors two novel mutations.
Chang YH; Ding DC
BMC Cancer; 2020 Nov; 20(1):1058. PubMed ID: 33143664
[TBL] [Abstract] [Full Text] [Related]
8. Cytogenomics of six human trophoblastic cell lines.
Weber M; Weise A; Vasheghani F; Göhner C; Fitzgerald JS; Liehr T; Markert UR
Placenta; 2021 Jan; 103():72-75. PubMed ID: 33096371
[TBL] [Abstract] [Full Text] [Related]
9. Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.
Momeni-Boroujeni A; Mohammad N; Wolber R; Yip S; Köbel M; Dickson BC; Hensley ML; Leitao MM; Antonescu CR; Benayed R; Ladanyi M; Lee CH; Chiang S
Mod Pathol; 2021 May; 34(5):1008-1016. PubMed ID: 33077922
[TBL] [Abstract] [Full Text] [Related]
10. Recurrent urothelial carcinoma-like fgfr3 genomic alterations in malignant Brenner tumors of the ovary.
Lin DI; Killian JK; Venstrom JM; Ramkissoon SH; Ross JS; Elvin JA
Mod Pathol; 2021 May; 34(5):983-993. PubMed ID: 33077920
[TBL] [Abstract] [Full Text] [Related]
11. Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy.
Yoshimoto Y; Sasaki Y; Murata K; Noda SE; Miyasaka Y; Hamamoto J; Furuya M; Hirato J; Suzuki Y; Ohno T; Tokino T; Oike T; Nakano T
Gynecol Oncol; 2020 Nov; 159(2):546-553. PubMed ID: 32951893
[TBL] [Abstract] [Full Text] [Related]
12. Genomic Profiling Aids Classification of Diagnostically Challenging uterine Mesenchymal Tumors With Myomelanocytic Differentiation.
Selenica P; Conlon N; Gonzalez C; Frosina D; Jungbluth AA; Beets-Tan RGH; Rao MK; Zhang Y; Benayed R; Ladanyi M; Solit DB; Chiang S; Hyman DM; Hensley ML; Soslow RA; Weigelt B; Murali R
Am J Surg Pathol; 2021 Jan; 45(1):77-92. PubMed ID: 32889887
[TBL] [Abstract] [Full Text] [Related]
13. FGFR Signaling as a Candidate Therapeutic Target for cancers Resistant to Carbon Ion Radiotherapy.
Darwis NDM; Nachankar A; Sasaki Y; Matsui T; Noda SE; Murata K; Tamaki T; Ando K; Okonogi N; Shiba S; Irie D; Kaminuma T; Kumazawa T; Anakura M; Yamashita S; Hirakawa T; Kakoti S; Hirota Y; Tokino T; Iwase A; Ohno T; Shibata A; Oike T; Nakano T
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540114
[TBL] [Abstract] [Full Text] [Related]
14. Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study.
Leone Roberti Maggiore U; Martinelli F; Dondi G; Bogani G; Chiappa V; Evangelista MT; Liberale V; Ditto A; Ferrero S; Raspagliesi F
J Gynecol Oncol; 2019 Jul; 30(4):e57. PubMed ID: 31074240
[TBL] [Abstract] [Full Text] [Related]
15. Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study.
Liu GC; Zhou YF; Su XC; Zhang J
BMC Cancer; 2019 Jan; 19(1):24. PubMed ID: 30616520
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive genomic profiling aids in treatment of a metastatic endometrial cancer.
Dhami J; Hirshfield KM; Ganesan S; Hellmann M; Rojas V; Amorosa JK; Riedlinger GM; Zhong H; Ali SM; Pavlick D; Elvin JA; Rodriguez-Rodriguez L
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29588307
[No Abstract] [Full Text] [Related]
17. The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National cancer Database analysis.
Lee JK; Ghanem AI; Modh A; Burmeister C; Mahmoud O; Maxwell GL; Elshaikh MA
Brachytherapy; 2018; 17(2):319-325. PubMed ID: 29174935
[TBL] [Abstract] [Full Text] [Related]
18. Endometrial cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model.
Taurin S; Yang CH; Reyes M; Cho S; Coombs DM; Jarboe EA; Werner TL; Peterson CM; Janát-Amsbury MM
Int J Gynecol Cancer; 2018 Jan; 28(1):152-160. PubMed ID: 28953502
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: A meta-analysis and systematic review.
Wei J; Zhang W; Feng L; Gao W
Medicine (Baltimore); 2017 Sep; 96(37):e8034. PubMed ID: 28906392
[TBL] [Abstract] [Full Text] [Related]
20. Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients.
Choi CH; Chung JY; Kim JH; Kim BG; Hewitt SM
J Transl Med; 2016 May; 14(1):124. PubMed ID: 27154171
[TBL] [Abstract] [Full Text] [Related]
[Next]
